Abstract:Cornea blindness is still treated mainly by corneal transplantation, using donated allograft human corneas. However, a severe global shortfall leaves an estimated 12.7 million patients on waiting lists despite methods of using one cornea for two different partial‐thickness grafts. Even more individuals are not on waiting lists because they have no access to transplantation in their countries or regions. However, even if donor tissues were readily available, patients with inflamed, severely damaged corneas are at high risk of rejecting conventional transplantation. Various solutions have been proposed as alternatives to corneal allografting, including the development of keratoprostheses and stem cell grafting. We posited using cell‐free implants that mimic the extracellular matrix of the human cornea to recapitulate the environment during corneal development and stimulate the endogenous cells within the patient's eyes to affect regeneration. We used cell‐free corneal implants made from chemically crosslinked recombinant human collagen to promote in situ tissue regeneration in pathologic corneas, including high‐risk ones. We successfully developed and tested recombinant human solid collagen‐based implants that promoted stable regeneration in inflamed human patient corneas based on phosphorylcholine (MPC). However, solid corneas require a full operating theatre and staffing, which is costly and not accessible to more remote regions in Canada and globally. Burns and severe infections that can lead to perforations are medical emergencies that require immediate methods to seal the eye. In many centres, cyanoacrylate glue is used as a sealant, but this is toxic and kills surrounding cells, often necessitating follow‐on transplantation. We developed a synthetic, biocompatible, and adhesive liquid hydrogel (LiQD Cornea), which would replace these toxic cyanoacrylate glues. LiQD cornea is applied as a liquid but quickly adheres and gels within corneal tissue defects like a dental filling. It can be used to fill ulcers and other damaged areas. Then its similarity at a molecular level to a natural tissue framework promotes tissue regeneration, treating corneal perforations effectively without transplantation. Further, due to the synthetic nature of the material, risks associated with disease transmission are reduced compared to natural products. We see LiQD Cornea potentially used in outpatient clinics instead of operating theatres, maximizing practicality and minimizing health care costs.

Arrested Phase Separation Enables High-Performance Keratoprostheses.

Short‐term Results of Acellular Porcine Corneal Stroma Keratoplasty for Herpes Simplex Keratitis

T-style Keratoprosthesis Based on Surface-Modified Poly (2-Hydroxyethyl Methacrylate) Hydrogel for Cornea Repairs.

Natural Extracellular Matrix Scaffold-Based Hydrogel Corneal Patch with Temperature and Light-Responsiveness for Penetrating Keratoplasty and Sutureless Stromal Defect Repair.

Recombinant Human Collagen Hydrogels with Hierarchically Ordered Microstructures for Corneal Stroma Regeneration

Tissue Engineering of Corneal Stroma Via Melt Electrowriting

Potential of an Amphiphilic Artificial Corneal Endothelial Layer as a Replacement Option for Damaged Corneal Endothelium

3D bioprinting for artificial cornea: Challenges and perspectives.

Integrated 3D Bioprinting-Based Geometry-Control Strategy for Fabricating Corneal Substitutes

Engineering copolymeric artificial cornea with salt porogen

3D Printing of Stiff, Tough, and ROS-Scavenging Nanocomposite Hydrogel Scaffold for in Situ Corneal Repair

3D-Printed Nano-Structural Poly(Epsilon-Caprolactone) (pcl) Scaffolds for Corneal Stromal Regeneration

Preparation, Physico-Biochemical Characterization, and Proteomic Analysis of Highly Transparent Corneal Extracellular Matrices for Lamellar Keratoplasty and Tissue-Engineered Cornea Construction

A "T.E.S.T." hydrogel bioadhesive assisted by corneal cross-linking for in situ sutureless corneal repair

Mechanical and Optical Properties of Reinforced Collagen Membranes for Corneal Regeneration Through Polyrotaxane Cross-Linking.

Dual-crosslinked regenerative hydrogel for sutureless long-term repair of corneal defect

Corneal stromal structure replicating humanized hydrogel patch for sutureless repair of deep anterior-corneal defect

Triple-crosslinked double-network alginate/dextran/dendrimer hydrogel with tunable mechanical and adhesive properties: A potential candidate for sutureless keratoplasty

A porous collagen-based hydrogel and implantation method for corneal stromal regeneration and sustained local drug delivery

Porous Hydrogel Constructs Based on Methacrylated Gelatin/polyethylene Oxide for Corneal Stromal Regeneration

Synthetic solutions for re‐growing human corneas